A Study of Enzalutamide and LY3023414 in Men With Prostate Cancer

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2015
The main purpose of this study is to evaluate the safety and effectiveness of the study drug known as LY3023414 in combination with enzalutamide in men with prostate cancer.
Epistemonikos ID: 6d2cc3840e73b4c3099e6d6b8400de48a27c9f7e
First added on: May 12, 2024